Ancell anti-CD64(FcRI) F(ab’)2 used to block Phagocytosis of opsonized plateletsBy Paul Everson / November 2, 2022 This study looked at the effect of glycosylation of anti-platelet antibody on ability of Macrophage mediated phagocytotic clearance in transfusion patients. F(ab’)2 of anti-CD64 mAb was used as a phagocytosis blocking control in vitro. “Phagocytosis of platelets opsonized with differently glycosylated anti-HLA hIgG1 by monocyte-derived macrophages“ Thijs L, Gesture Vidarsson, et al. Platelets (2022) https://doi.org/10.1080/09537104.2022.2129604 PMID: 36185007 Ancell anti-human Fc Receptor Antibodies, Fab, F(ab’)2, conjugates anti-CD16 (FcgRIII) anti-CD32 (FcgRII) anti-CD64 (FcgRI)
